Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Chatenay-Rivauday

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Molecular Biology Reports|August 6, 2004
Caveolae: biochemical analysisChristian Chatenay-Rivauday, Z Petek Cakar, Paul Jenö, et al.
Cancer Discovery|August 10, 2012
Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growthFred Harbinski, Vanessa J Craig, Sneha Sanghavi, et al.
Molecular Cancer Therapeutics|March 11, 2014
Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trialsChristine Fritsch, Alan Huang, Christian Chatenay-Rivauday, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Molecular Biology Reports|August 6, 2004
Caveolae: biochemical analysisChristian Chatenay-Rivauday, Z Petek Cakar, Paul Jenö, et al.
Cancer Discovery|August 10, 2012
Rescue screens with secreted proteins reveal compensatory potential of receptor tyrosine kinases in driving cancer growthFred Harbinski, Vanessa J Craig, Sneha Sanghavi, et al.
Molecular Cancer Therapeutics|March 11, 2014
Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trialsChristine Fritsch, Alan Huang, Christian Chatenay-Rivauday, et al.
Pageof 1